by Richard Daverman, PhD
September 14, 2012 -- Qiagen, the Dutch medical device company, has teamed up with Lepu Medical Technology (Beijing). The two companies will combine their diagnostic devices, which Lepu will then market in China. The two devices are Qiagen’s ESEQuant Lateral Flow System, a test reader, and Lepu’s cardiac marker tests that diagnose acute myocardial infarction. Lepu will market the combination under the name Lepu Quant-Gold. More details....
Stock Symbols: (NSDQ: QGEN) (SHE: 300003)
